![Joseph Vazzano](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joseph Vazzano
Financieel Directeur/CFO bij ABEONA THERAPEUTICS INC.
Vermogen: 922 030 $ op 30-06-2024
Actieve functies van Joseph Vazzano
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ABEONA THERAPEUTICS INC. | Comptroller/Controller/Auditor | 31-03-2022 | - |
Financieel Directeur/CFO | 14-03-2022 | - | |
ALLARITY THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-08-2023 | - |
Independent Dir/Board Member | 01-08-2023 | - | |
Allarity Therapeutics A/S
![]() Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Directeur/Bestuurslid | - | - |
Independent Dir/Board Member | - | - |
Loopbaan van Joseph Vazzano
Eerdere bekende functies van Joseph Vazzano
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AVENUE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 15-08-2017 | 08-02-2019 |
Financieel Directeur/CFO | 15-08-2017 | 07-01-2022 | |
Bedrijfssecretaris | 08-02-2019 | 07-01-2022 | |
INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2016 | 01-07-2017 |
KPMG LLP
![]() KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Pernix Therapeutics, Inc. | Corporate Officer/Principal | - | - |
Opleiding van Joseph Vazzano
Lehigh University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
2 | |
Denemarken | 2 |
Operationeel
Corporate Officer/Principal | 3 |
Comptroller/Controller/Auditor | 2 |
Director of Finance/CFO | 2 |
Sectoraal
Health Technology | 7 |
Consumer Services | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
AVENUE THERAPEUTICS, INC. | Health Technology |
INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
ABEONA THERAPEUTICS INC. | Health Technology |
ALLARITY THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Pernix Therapeutics, Inc. | Health Technology |
KPMG LLP
![]() KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
Allarity Therapeutics A/S
![]() Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
- Beurs
- Insiders
- Joseph Vazzano
- Ervaring